YICHANG HUMANWELL PHARMACEUTICAL CO LTD

Overview

YICHANG HUMANWELL PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 30 active FDA Type II Drug Master Files, covering 16A-HYDROXYPREDNISOLONE (INTERMEDIATE); 16ALPHA-HYDROXYPREDNISOLONE; 17-IODOANDROSTA-5,16-DIENE-3ß-O1 (INTERMEDIATE); ABIRATERONE ACETATE; APALUTAMIDE; BUDESONIDE.

API / Drug Master Files

YICHANG HUMANWELL PHARMACEUTICAL CO LTD holds 30 active (31 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DESONIDEActive2026-03-09
• DROSPIRENONEActive2026-03-01
• ESTRADIOL HEMIHYDRATEActive2026-02-06
• CLASCOTERONEActive2026-01-19
• 17-IODOANDROSTA-5,16-DIENE-3ß-O1 (INTERMEDIATE)Active2025-11-25
• TESTOSTERONE CYPIONATEActive2025-09-22
• ESLICARBAZEPINE ACETATEActive2025-09-19
• VALGANCICLOVIR HYDROCHLORIDEActive2025-06-25
• APALUTAMIDEActive2025-01-26
• TESTOSTERONE UNDECANOATEActive2024-08-23
• LASMIDITAN HEMISUCCINATEActive2024-07-27
• MIRABEGRONActive2023-03-24
• DIENOGESTActive2023-01-18
• ABIRATERONE ACETATEActive2023-01-16
• TESTOSTERONEActive2022-09-07

Showing 15 of 31 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to YICHANG HUMANWELL PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.